The European Medicines Agency (EMA) has recommended a recall of three drugs used in cancer therapy following an inspection of a US based manufacturing site which high lighted several quality assurance problems in the sterilisation process.
Two of the drugs, Busilex and Velcade (used for the treatment of bone marrow cancer) manufactured by Ben Venue in the United States, are available in the UK and Ireland. The batches are being recalled as a precaution due to a risk of contamination. Alternative manufacturers of these products are supplying the EU and the UK and Irish markets and shortages are not anticipated. Patients have been advised to continue their treatment.
Speaking today about the latest recall Liam Moloney, Product Liability Solicitor, said, “if any patients are taking these drugs they should immediately talk to their GP or healthcare professional for advice. At the moment the affected batch numbers of the stock are unknown but patients should liaise with the Irish Medicines Board to identify exactly the specific drugs that have to be recalled”.
For further information contact:
Liam Moloney, Solicitor
Tel: 045 898000
Email: liammoloney@moloneysolicitors.ie
